Concepedia
Statistics
Publications
40
Citations
3.7K
H-Index
26
Active since
2003
Affiliations
University of California, Berkeley(Current)
University of California, Davis
AbbVie (United States)
GlaxoSmithKline (United States)
Pfizer (United States)
Ola M. Saad is an author at University of California, Berkeley specializing in medicine, pharmacology, and immunology.
Top concepts
MedicinePharmacologyImmunologyImmunotherapyDrug DiscoveryAntibody EngineeringBioanalysisPharmacotherapyBiochemistryNatural Sciences
Publications per year
2003–2024
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
Ben‐Quan Shen, Keyang Xu, Luna Liu et al. · Nature Biotechnology · 2012 · 977 citations
Immunoengineering, Immunology, Bioconjugation +8
Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody–drug conjugate in development for the treatment of HER2-positive cancer
Sandhya Girish, Manish Gupta, Bei Wang et al. · Cancer Chemotherapy and Pharmacology · 2012 · 261 citations · Full text
Bioanalytical Assay Strategies for The Development of Antibody–Drug Conjugate Biotherapeutics
Surinder Kaur, Keyang Xu, Ola M. Saad et al. · Bioanalysis · 2013 · 227 citations
Immunocytochemical Technique, Immunology, Immunotherapeutics +19
Impact of Drug Conjugation on Pharmacokinetics and Tissue Distribution of Anti-STEAP1 Antibody–Drug Conjugates in Rats
C. Andrew Boswell, Eduardo E. Mundo, Crystal Zhang et al. · Bioconjugate Chemistry · 2011 · 200 citations
Nanotherapeutics, Local Pharmacology, Immunology +23
Potential Mechanisms for Thrombocytopenia Development with Trastuzumab Emtansine (T-DM1)
Hirdesh Uppal, Estelle Doudement, Kaushiki Mahapatra et al. · Clinical Cancer Research · 2014 · 199 citations
1–5 of 40